Citations

Clear

6 citation(s) found for "Harper, Sarah B".

Coordinating Multisector Efforts to Address Social Needs in a Rural Midwestern Primary Care Setting
Savitz, Samuel T. , Paul, Margaret M. , Mauerman, Gretchen E., Glasgow, Amy E. , Harper, Sarah B., McCoy, Jessica, Westfall, Erin , Harper, Sarah B , McCoy, Jessica J, Westfall, Erin , Harper, Sarah B. , Paul, Margaret M , Mauerman, Gretchen

Mayo Clinic

Journal of Primary Care & Community Health | July 28, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261472633 | PMID 42521199 Get It

Introduction/Objectives The rise in screening for social drivers of health (SDoH) in primary care settings has led to questions about effective intervention design. A large primary care practice at Mayo Clinic developed a model centered on a full-time Health Equity Coordinator (HEC) to facilitate clinic-community partnerships in 2022. The goal of this analysis was to assess the model on process outcomes, resolution of SDoH needs, and changes in healthcare utilization. Methods Using a cohort study design, we identified primary care patients with unmet SDoH needs at the intervention clinic and two comparator clinics from March 2022 to December 2023. We assessed process outcomes descriptively and resolution of SDoH needs and healthcare utilization using multivariable regression. Results The HEC contacted 348 patients and conducted 748 meetings with community-based organization staff. While there were decreases for SDoH needs and missed or late cancelled appointments in intervention group, there were no significant difference in resolution of SDoH and healthcare utilization relative to comparator groups. Conclusions The HEC model for multi-stakeholder coordination showed promise in referring patients to services and engaging key stakeholders in a primary care setting. Longer term follow up may be needed to identify changes in SDoH needs and healthcare utilization.
Colon-Pilot: A Generative AI Tool for Automated Colonoscopy Surveillance Recommendations and 2024 ACG/ASGE Quality Benchmarking
Garg, Sushil Kumar , Mau, Brayden , Hubers, Jeffery , Arce, Victor, Hooper, Nicole, Lindquist, Jennifer, Harper, Sarah B. , Thayer, Ann B., Mukherjee, Piyush, Loufek, Brenna, Melnick, Joe , Rost, Lauren, Robbins, Steven A. , Chaudhary, Rajeev, Harper, Sarah B , Loufek, Brenna T , Rost, Lauren M , Gomes, Rahul , Chaudhary, Rajeev , Hubers, Jeffrey , Arce, Victor, Mukherjee, Piyush, Rost, Lauren M. , Gomes, Rahul

Mayo Clinic

American Journal of Gastroenterology | February 10, 2026 | Volume: 121 | Issue: 4 | Pages: 964-973

10.14309/ajg.0000000000003946 | PMID 41665228 Get It

INTRODUCTION: High-quality colonoscopy requires accurate risk stratification for surveillance per the 2020 US Multi-Society Task Force guidelines and adherence to 2024 American College of Gastroenterology/American Society for Gastrointestinal Endoscopy quality benchmarks. Both are operationally challenging in clinical practice. We developed and validated Colon-Pilot, a large language model—powered clinical decision support system using GPT-4o to automate and standardize both functions. METHODS: The system was evaluated in 2 operational modes: (i) a human-in-the-loop clinical decision support validation of surveillance recommendations for 596 colonoscopies, comparing concordance with 2020 US Multi-Society Task Force guidelines against expert consensus, and (ii) an automated administrative audit applying Colon-Pilot to 42,632 colonoscopies across the Mayo Clinic Health System to calculate 2024 American College of Gastroenterology/American Society for Gastrointestinal Endoscopy priority quality indicators. Recommendations were autogenerated unless predefined safety criteria triggered manual review. RESULTS: Colon-Pilot issued recommendations for 522 of 596 cases (87.6%) and flagged 12.4% for manual review. For automated cases, guideline-concordant accuracy was 97.5% (Cohen κ = 0.970) versus 69.7% (κ = 0.781) for original endoscopist recommendations. Discordant artificial intelligence (AI) cases (n = 13) most often recommended longer-than-appropriate intervals (62%). Applied to the enterprise data set, Colon-Pilot calculated performance exceeding 2024 targets: adenoma detection rate 49.8% (≥35%), sessile serrated lesion detection rate 17.7% (≥6%), bowel preparation adequacy 91.8% (≥90%), and cecal intubation rate 97.4% (≥95%). DISCUSSION: Colon-Pilot demonstrated high fidelity in applying surveillance guidelines and automated quality benchmarking, outperforming unassisted endoscopists in guideline adherence. By combining safety protocols with large-scale automated reporting, it offers a scalable solution for improving both efficiency and quality in colorectal cancer prevention.
Comparing trends in telehealth utilization by medical oncology practices at Stanford Medicine and Mayo Clinic from 2019–2023.
Parameswaran, Vijaya , Miller, Marci, Grimm, Jessica, Gullerud, Rachel E., Fan, Winnie, Gibbons, Daniel J., Oyarzabal, Beatriz A., Lunde, Julianne J. , Rosengaus, Leah, Sharp, Christopher , Shah, Sumit , Haddad, Tufia C. , Grimm, Jessica, Coffey, Jordan , Harper, Sarah, Demaerschalk, Bart M. , Pritchett, Joshua C.

Mayo Clinic

Journal of Clinical Oncology | May 28, 2025 | Volume: 43 | Issue: 16_suppl | Pages: No page available

10.1200/jco.2025.43.16_suppl.e13890 Get It

e13890 Background: Many oncology practices have reported continued use of telemedicine since onset of the COVID-19 pandemic. However, the future sustainability of telemedicine within oncology practices remains unclear, particularly because federal policies that enabled adoption in response to the public health emergency (PHE) have not been made permanent. Understanding similarities and differences in telemedicine utilization at high-volume oncology centers is crucial for shaping evidence-based policy that enables equitable access to oncology care across varying geographies. Methods: This is a cross-sectional, year-over-year, retrospective cohort analysis of trends in telemedicine utilization across all medical oncology clinical appointments conducted among adult patients (age >18) from January 2019 to December 2023 at Stanford Medicine Cancer Center (SM) – comprising multiple campuses in the California Bay Area – and the Mayo Clinic Comprehensive Cancer Center (MC) – a multiregional cancer practice with tertiary referral campuses in Minnesota, Florida, and Arizona, as well as community-based clinics throughout the Upper Midwest. Results: Both institutions exhibited a similar trend in telemedicine adoption over time. This was characterized by an initial surge in utilization following the PHE declaration in March 2020, followed by sustained utilization rates from 2021 to 2023. However, telemedicine use as a proportion of the overall practice differed significantly between institutions. At SM, the rate of telemedicine visits as a proportion of overall clinical practice was 60.3% (49,136/ 81,502) in 2021, 59.9% (52,247/ 87,215) in 2022, and 57.2% (55,007/ 96,163) in 2023. At MC, the proportion of telemedicine utilization was 12.8% in 2021 (23,873/186,086), 14.7% in 2022 (28,985/196,777), and 14.0% in 2023 (30,208/215,941). Deployment in the setting of new versus return visits also differed between institutions. In 2023, telemedicine accounted for 53.7% (6,440/11,998) of new and 57.7% (48,567/84,165) of return visits at SM, compared to 15.5% (3,359/21,728) and 13.8% (26,849/194,213) at MC. Additionally, while video visits were the predominant modality used to conduct telemedicine visits at both institutions from 2021 onward, in 2023 phone visits still made up 17.9% (5,394/30,208) of all telemedicine visits at MC, compared to just 5.4% (2,990/55,007) at SM. Conclusions: Stanford Medicine and Mayo Clinic exhibited a pattern of initial growth of telemedicine adoption in 2020, followed by sustained utilization from 2021-2023. We observed unique differences in the overall proportion, visit type deployment, and modality of telemedicine utilization between institutions. However, this study confirms telemedicine visits have remained a fixture of medical oncology care for many patients at these institutions since the COVID-19 pandemic.
Compass rose for generating community–based referrals: Best practices and lessons learned
Westfall, Erin , Sosso, Jessica , Harper, Sarah, Bishop, Alyssa, Canan, Liz, Chaudhry, Rajeev , Davis, M. R. , Mackinson, Brian, Marfilius, Traci, Mauerman, Gretchen, Zuehlke, Karen, Paul, Maggie, Westfall, Erin , Harper, Sarah, Bishop, Alyssa, Davis, Marquita, Paul, Maggie

Mayo Clinic

Health Services Research | April 7, 2025 | Volume: 60 | Issue: S1 | Pages: No page available

10.1111/1475-6773.14587 Get It

Development and acceptability of a mobile health application integrated with the electronic heath record for treatment of chronic insomnia disorder
Anderson, Sandra E., Wahl, Adam , Clark, Patrick, Smith, J.M. , Luedke, Tabitha C., McColley, Samantha , Phillips, Sarah A. , Harper, Sarah B , Boudreau, Nancy B., Monson, Amanda J., Morgenthaler, Timothy I. , Kolla, Bhanu Prakash , Smith, Justin M, Smith, Justin , Luedke, Tabitha Crystal

Mayo Clinic

Journal of Clinical Sleep Medicine | August 15, 2022 | Volume: 18 | Issue: 12 | Pages: 2785-2792

10.5664/jcsm.10218 | PMID 35959953 Get It

0457 Development and utility of a mobile health application integrated with the electronic heath record for treatment of chronic insomnia disorder
Kolla, Bhanuprakash , Luedke, Tabitha, McColley, Samantha , Phillips, Sarah , Smith, J.M. , Boudreau, Nancy , Morgenthaler, Timothy I. , Kolla, Bhanu Prakash , Anderson, Sandra , Luedke, Tabitha Crystal, Smith, Justin, Boudreau, Nancy, Harper, Sarah

Mayo Clinic

Sleep | May 31, 2022 | Volume: 45 | Issue: Supplement_1 | Pages: A202-A203

10.1093/sleep/zsac079.454 Get It

Abstract Introduction Cognitive behavior therapy for insomnia (CBT-I), a first-line therapy for patients with chronic insomnia disorder (ChID), is underutilized due to reduced access to trained providers and other barriers. We developed an interactive care plan (ICP) combining individual aspects of CBT-I. This ICP, which integrates with the electronic health record (EHR), is designed to deliver personalized and scalable CBT-I to patients with ChID. We report data from initial implementation and evaluation of a ChID ICP deployed at a tertiary sleep medicine clinic. Methods The ICP was developed following patient and provider interviews and focus groups. Patients diagnosed with ChID were offered enrollment and engaged in the ICP through an app. The ICP has embedded logic that may escalate care or offer an exit from the program, depending upon the patient’s response to questions. Key variables ascertained from the patient included sleep efficiency (SE), sleep timing and the Insomnia Severity Index (ISI), and how satisfied they were with their progress (Likert scale). We also measured In Basket messaging related to use of the ICP. Results A total of 222 patients [57% female, age=56.4±15.9 years (average ±SD), 92.7% white] were enrolled in the initial 120 days of ICP implementation. Most referrals were initiated by physicians or advanced practitioners (77.9%). ISI at initiation was 15±5.18 and SE was 74.55±16.65%. Patients spent 35.9±26.25 days engaging with the ICP. The ISI score at 28 days was 12.89±4.98 and SE was 78.9±13.4% with both showing significant improvement from baseline (p=0.013; p=0.002; respectively). Self-rated satisfaction with progress did not significantly correlate with actual improvement in ISI or SE (p>0.05). The ICP generated 3.89±2.3 In Basket messages per patient. Conclusion Patients who actively engaged with the ICP showed significant improvements in insomnia severity and sleep efficiency. While a majority of the patients were neutral towards the ICP and only a small minority expressed dissatisfaction, these data indicate that the ICP will have clinical utility in busy sleep medicine practices with reduced access to behavioral sleep specialists. Support (If Any)